Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nguyen Viet Nhung

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 30, 2023
Lung Cancer Screening in Asia: An Expert Consensus ReportDavid Chi-Leung Lam, Chong-Kin Liam, Sita Andarini, et al.
Medrxiv : the Preprint Server for Health Sciences|April 8, 2024
Solicited Cough Sound Analysis for Tuberculosis Triage Testing: The CODA TB DREAM Challenge DatasetSophie Huddart, Vijay Yadav, Solveig K Sieberts, et al.
Scientific Data|October 18, 2024
A dataset of Solicited Cough Sound for Tuberculosis Triage TestingSophie Huddart, Vijay Yadav, Solveig K Sieberts, et al.
NEJM Evidence|December 18, 2024
A Meta-Analysis of Levofloxacin for Contacts of Multidrug-Resistant TuberculosisTrinh Duong, Joanna Brigden, H Simon Schaaf, et al.
Emerging Infectious Diseases|February 23, 2022
Overseas Treatment of Latent Tuberculosis Infection in US-Bound ImmigrantsAmera Khan, Christina R Phares, Hoang Lan Phuong, et al.
Journal of Clinical Microbiology|October 27, 2021
Bedaquiline Drug Resistance Emergence Assessment in Multidrug-Resistant Tuberculosis (MDR-TB): a 5-Year Prospective <i>In Vitro</i> Surveillance Study of Bedaquiline and Other Second-Line Drug Susceptibility Testing in MDR-TB IsolatesKoné Kaniga, Rumina Hasan, Ruwen Jou, et al.
American Journal of Respiratory and Critical Care Medicine|July 16, 2024
Pyrazinamide Safety, Efficacy, and Dosing for Treating Drug-Susceptible Pulmonary Tuberculosis: A Phase 3, Randomized Controlled Clinical TrialAva Y Xu, Gustavo E Velásquez, Nan Zhang, et al.
The New England Journal of Medicine|December 18, 2024
Levofloxacin for the Prevention of Multidrug-Resistant Tuberculosis in VietnamGreg J Fox, Nguyen Viet Nhung, Nguyen Cam Binh, et al.
Nature Communications|October 31, 2024
Risk-stratified treatment for drug-susceptible pulmonary tuberculosisVincent K Chang, Marjorie Z Imperial, Patrick P J Phillips, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2025
Neoadjuvant Osimertinib for Resectable <i>EGFR</i>-Mutated Non-Small Cell Lung CancerJianxing He, Masahiro Tsuboi, Walter Weder, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 30, 2023
Lung Cancer Screening in Asia: An Expert Consensus ReportDavid Chi-Leung Lam, Chong-Kin Liam, Sita Andarini, et al.
Medrxiv : the Preprint Server for Health Sciences|April 8, 2024
Solicited Cough Sound Analysis for Tuberculosis Triage Testing: The CODA TB DREAM Challenge DatasetSophie Huddart, Vijay Yadav, Solveig K Sieberts, et al.
Scientific Data|October 18, 2024
A dataset of Solicited Cough Sound for Tuberculosis Triage TestingSophie Huddart, Vijay Yadav, Solveig K Sieberts, et al.
NEJM Evidence|December 18, 2024
A Meta-Analysis of Levofloxacin for Contacts of Multidrug-Resistant TuberculosisTrinh Duong, Joanna Brigden, H Simon Schaaf, et al.
Emerging Infectious Diseases|February 23, 2022
Overseas Treatment of Latent Tuberculosis Infection in US-Bound ImmigrantsAmera Khan, Christina R Phares, Hoang Lan Phuong, et al.
Journal of Clinical Microbiology|October 27, 2021
Bedaquiline Drug Resistance Emergence Assessment in Multidrug-Resistant Tuberculosis (MDR-TB): a 5-Year Prospective <i>In Vitro</i> Surveillance Study of Bedaquiline and Other Second-Line Drug Susceptibility Testing in MDR-TB IsolatesKoné Kaniga, Rumina Hasan, Ruwen Jou, et al.
American Journal of Respiratory and Critical Care Medicine|July 16, 2024
Pyrazinamide Safety, Efficacy, and Dosing for Treating Drug-Susceptible Pulmonary Tuberculosis: A Phase 3, Randomized Controlled Clinical TrialAva Y Xu, Gustavo E Velásquez, Nan Zhang, et al.
The New England Journal of Medicine|December 18, 2024
Levofloxacin for the Prevention of Multidrug-Resistant Tuberculosis in VietnamGreg J Fox, Nguyen Viet Nhung, Nguyen Cam Binh, et al.
Nature Communications|October 31, 2024
Risk-stratified treatment for drug-susceptible pulmonary tuberculosisVincent K Chang, Marjorie Z Imperial, Patrick P J Phillips, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2025
Neoadjuvant Osimertinib for Resectable <i>EGFR</i>-Mutated Non-Small Cell Lung CancerJianxing He, Masahiro Tsuboi, Walter Weder, et al.
Pageof 5